A detailed history of Stonnington Group, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Stonnington Group, LLC holds 2,500 shares of JAZZ stock, worth $307,425. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,500
Previous 2,500 -0.0%
Holding current value
$307,425
Previous $398,000 8.29%
% of portfolio
0.1%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 20, 2022

SELL
$126.59 - $161.18 $227,862 - $290,124
-1,800 Reduced 41.86%
2,500 $331,000
Q2 2022

Jul 08, 2022

SELL
$141.59 - $168.66 $325,657 - $387,918
-2,300 Reduced 34.85%
4,300 $681,000
Q1 2022

Apr 12, 2022

SELL
$129.64 - $160.7 $1.41 Million - $1.75 Million
-10,900 Reduced 62.29%
6,600 $1.06 Million
Q4 2021

Jan 12, 2022

BUY
$119.87 - $145.67 $1.8 Million - $2.19 Million
15,000 Added 600.0%
17,500 $2.62 Million
Q1 2021

May 21, 2021

BUY
$150.19 - $173.5 $375,475 - $433,750
2,500 New
2,500 $440,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Stonnington Group, LLC Portfolio

Follow Stonnington Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.